Australian firm Bionic Vision Technologies (BVT) has scored a AUS$23m ($18m) cash investment from Hong Kong-based backers to advance its retinal implant aimed at restoring vision to the blind.
BVT said it would use the funds to begin human clinical trials of its "bionic eye" in patients with the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?